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Introduction 
Esophageal and junctional adenocarcinoma (EAC) has a 7-to-1 male predominance.(1) The 
main risk factors for EAC, obesity and gastroesophageal reflux, are however equally 
distributed between sexes.(2-4) A predominantly abdominal fat distribution, typical for 
males, is however a stronger risk factor than BMI,(5-8) and abdominal adiposity might 
facilitate reflux through increased intra-abdominal pressure. Abdominal adiposity has 
therefore been suggested to explain the male predominance of EAC.  If true, the male-to-
female sex ratio in EAC would be low, or absent, among lean patients and high among 
overweight. We aimed to test this hypothesis.  
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Methods 
We analyzed data from a population-based nationwide Swedish case-control study, which 
has been described in detail elsewhere.(3) In brief, participants were prospectively included 
in 1995-1997. Cases were recruited from all 195 Swedish hospital departments involved in 
these patients. Tumor classification was comprehensive and uniform. Controls were 
randomly selected and frequency-matched for age and sex of EAC cases. Due to the 
matching on sex, controls were used to estimate person-years by employing data from the 
Swedish Register of the Total Population. At personal interviews information on BMI was 
assessed as: 1) 20 years before interview, 2) 20 years of age, 3) maximum adult BMI, and 4) 
minimum adult BMI. Incidence rate ratio estimated relative risk (RR). Person-years were 
calculated by age (<60, 60-69, or 70-79), sex and BMI (<22, 22-<25, or ≥25) derived from the 
Swedish population. The BMI-distribution in controls was used to estimate person-years in 
the population. Poisson regression was used to calculate RR and 95% confidence intervals 
(CI), where log-transformed person-years were included in the model as an offset. To 
evaluate effect modification of BMI on the association between sex and EAC, we included 
age, sex, BMI and an interaction term between sex and BMI in the model. Likelihood ratio χ2 
statistics was used to obtain P-value for test of effect modification.  
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Results 
Included were 451 EAC cases (85% participation) and 820 controls (73%). The male-to-
female ratio was 7-to-1. Half of the EAC cases were overweight (BMI ≥25) 20 years before 
interview. There was no increased RR with increasing levels of BMI in any of the BMI-
assessments (Table). Regarding BMI 20 years before interview, the male predominance in 
overweight participants (RR 5.8, 95%CI 3.9-8.8) was not higher than in lean (RR 7.4, 95%CI 
3.9-14.1). The corresponding RRs at age 20 were similar (RR 7.2, 95%CI 3.6-14.3 and RR 7.2, 
95%CI 4.8-10.6, respectively). Regarding minimum BMI, there was rather a higher male 
predominance in lean participants, and for maximum BMI the male predominance was at 
least as strong in lean (Table).  
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Discussion 
This study provides no support for the hypothesis that an increased male predominance of 
EAC correlates with higher BMI. 
The population-based design with high participation rates and the possibility to estimate 
person-years from population-based controls were prerequisites for the study. Recording of 
all Swedish residents enabled assessment of person-years at risk from which the cases were 
derived, and thus possible to adjust for age. Other advantages include the thorough tumor 
classification, personal interviews, and assessment of BMI at different time points. Among 
weaknesses is possible misclassification of BMI, but any such bias should be similar between 
cases and controls. Moreover, the low incidence of EAC in women reduced the statistical 
power.        
In conclusion, although abdominal adiposity is clearly overrepresented in men and there is a 
strong male predominance in EAC, this population-based study with a nearly complete 
assessment of EAC cases in Sweden found no evidence of an increased age-adjusted male 
predominance with higher levels of BMI, which argues against abdominal obesity being a key 
factor in explaining the male predominance.  
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Table. Age-adjusted relative risk (RR) and 95% confidence interval (CI) of esophageal or 
gastroesophageal junctional adenocarcinoma in categories of body mass index (BMI) in 
males compared to females (reference category).  
 Body mass index  
BMI categories 
20 years before 
interview 20 years of age 
Minimum as 
adult 
Maximum as 
adult 
 RR (95% CI) RR (95% CI) RR (95% CI) RR (95% CI) 
<22 7.4 (3.9-14.1) 7.2 (4.8-10.6) 7.9 (5.4-11.5) 7.5 (1.7-33.8) 
22 - <25  5.3 (3.5-8.1) 4.2 (2.7-6.5) 3.6 (2.4-5.5) 8.5 (4.5-15.9) 
≥25  5.8 (3.9-8.8) 7.2 (3.6-14.3) 4.2 (1.9-9.3) 5.9 (4.3-7.9) 
P-value*  0.68 0.17 0.03 0.55 
 
* Test of effect modification   
 
 
 
